Heartland
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis
CONCLUSION: Although the primary endpoint was not reached, several signals suggest CBD-rich botanical extract may be beneficial for symptomatic treatment of UC.

Background: Cannabidiol (CBD) exhibits anti-inflammatory properties that could improve disease activity in inflammatory bowel disease. This proof-of-concept study assessed efficacy, safety and tolerability of CBD-rich botanical extract in ulcerative colitis (UC) patients.
Methods: Patients aged 18 years or older, with left-sided or extensive UC, Mayo scores of 4-10 (endoscopy scores ≥1), and on stable 5-aminosalicylic acid dosing, were randomized to 10-weeks’ CBD-rich botanical extract or placebo capsules. The primary endpoint was the percentage of patients in remission after treatment. Statistical testing was 2-sided, using a 10% significance level.
Results: Patients were less tolerant of CBD-rich botanical extract compared with placebo, taking on average one-third fewer capsules, and having more compliance-related protocol deviations (principally insufficient exposure), prompting identification of a per protocol (PP) analysis set. The primary endpoint was negative; end of treatment remission rates were similar for CBD-rich botanical extract (28%) and placebo (26%). However, PP analysis of total and partial Mayo scores favoured CBD-rich botanical extract (P = 0.068 and P = 0.038, respectively). Additionally, PP analyses of the more subjective physician’s global assessment of illness severity, subject global impression of change, and patient-reported quality-of-life outcomes were improved for patients taking CBD-rich botanical extract (P = 0.069, P = 0.003, and P = 0.065, respectively). Adverse events (AEs) were predominantly mild/moderate with many in the CBD-rich botanical extract group potentially attributable to the ∆9-tetrahydrocannabinol content. A greater proportion of gastrointestinal-related AEs, indicative of UC worsening, was seen on placebo.
Conclusion: Although the primary endpoint was not reached, several signals suggest CBD-rich botanical extract may be beneficial for symptomatic treatment of UC.
Heartland
Reliable cbd websites in the US ? Im not sure who to trust for quality
Visit our community site for vetted suppliers at http://theCBD.place. It’s time that this subject was given more internet exposure. We are here to discuss topics related to medical marijuana and our experiences using CBD. Please do not assume that anyone here is a medical professional.
Heartland
Cannabis and the Autistic Spectrum

Visit our community site for vetted suppliers at http://theCBD.place. It’s time that this subject was given more internet exposure. We are here to discuss topics related to medical marijuana and our experiences using CBD. Please do not assume that anyone here is a medical professional.
Source: https://www.reddit.com/r/CBD/comments/lta8xe/cannabis_and_the_autistic_spectrum/
Heartland
Is 0.5 grams too much for a beginner?
I just bought my very first pre-rolls! I started taking gummies every now and then about 3 months ago to help with my anxiety and panic attacks but i hear smoking gives you the desired effect much quicker.
The package says each roll is 0.5 grams but that sounds like a lot to me. Can anyone give me some advice?
Source: https://www.reddit.com/r/CBD/comments/lt9tz2/is_05_grams_too_much_for_a_beginner/
-
Heartland1 week ago
CBD Oil for Dogs With Seizures: The Ultimate Guide
-
Heartland1 week ago
Ag. secy. seeks grants to boost hemp sales
-
Heartland1 week ago
Biochemical aspects of seeds from Cannabis sativa L. plants grown in a mountain environment
-
Heartland1 week ago
Humboldt County, California, permanently bans hemp cultivation
-
News1 week ago
Fiore Cannabis Announces Sale of Surplus Cannabis Licence to Fund Expansion of Apex Cultivation Facility
-
News1 week ago
TILT Holdings Provides Preliminary Fourth Quarter Results, Operational Highlights and 2021 Outlook
-
Uncategorized1 week ago
How to Apply for a Massachusetts Cannabis License
-
News1 week ago
SpeakEasy Announces Closing of $4,302,500 Million Non-Brokered Private Placement